Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer.
Am J Clin Oncol. 1997 Dec;20(6):605-8. doi: 10.1097/00000421-199712000-00015.
Am J Clin Oncol. 1997.
PMID: 9391550